50 related articles for article (PubMed ID: 8700355)
1. [Procollagen type I C-propeptide in kidney transplant recipients].
Vaccaro F; Gioviale MC; Picone FP; Buscemi G; Romano M
Minerva Med; 1996 Jun; 87(6):269-73. PubMed ID: 8700355
[TBL] [Abstract][Full Text] [Related]
2. Procollagen type I carboxy-terminal propeptide as a marker of osteoblastic bone metastases.
Francini G; Gonnelli S; Petrioli R; Bruni S; Marsili S; Aquino A; Camporeale A
Cancer Epidemiol Biomarkers Prev; 1993; 2(2):125-9. PubMed ID: 8467247
[TBL] [Abstract][Full Text] [Related]
3. Short-term effect of parathyroidectomy on biochemical markers in primary and secondary hyperparathyroidism.
Hoshino H; Kushida K; Takahashi M; Denda M; Yamazaki K; Yamanashi A; Inoue T
Miner Electrolyte Metab; 1997; 23(2):93-9. PubMed ID: 9252975
[TBL] [Abstract][Full Text] [Related]
4. How useful are bone turnover markers in rheumatoid arthritis? Influence of disease activity and corticosteroid therapy.
Cortet B; Flipo RM; Pigny P; Duquesnoy B; Racadot A; Boersma A; Delcambre B
Rev Rhum Engl Ed; 1997 Mar; 64(3):153-9. PubMed ID: 9090763
[TBL] [Abstract][Full Text] [Related]
5. Bone marker alterations in patients with type 1 Gaucher disease.
Ciana G; Martini C; Leopaldi A; Tamaro G; Katouzian F; Ronfani L; Bembi B
Calcif Tissue Int; 2003 Mar; 72(3):185-9. PubMed ID: 12522660
[TBL] [Abstract][Full Text] [Related]
6. [Clinical usefulness of cross-linked N-telopeptide of type I collagen (NTx) as a bone metastatic marker in patients with prostate cancer--comparison with serum PICP, PINP and ICTP].
Kobayashi Y; Ochi M; Tokue A
Hinyokika Kiyo; 2000 Dec; 46(12):869-72. PubMed ID: 11211802
[TBL] [Abstract][Full Text] [Related]
7. Body mass index (BMI) and parameters of bone formation and resorption in postmenopausal women.
Papakitsou EF; Margioris AN; Dretakis KE; Trovas G; Zoras U; Lyritis G; Dretakis EK; Stergiopoulos K
Maturitas; 2004 Mar; 47(3):185-93. PubMed ID: 15036488
[TBL] [Abstract][Full Text] [Related]
8. Changes of bone markers during long-term intravenous calcitriol therapy in maintenance dialysis patients.
Lee SH; Huang TS; Hsieh SJ
Miner Electrolyte Metab; 1996; 22(4):219-23. PubMed ID: 8807625
[TBL] [Abstract][Full Text] [Related]
9. Impact of calcineurin inhibitors on bone metabolism in primary kidney transplant patients.
Bozkaya G; Nart A; Uslu A; Onman T; Aykas A; Doğan M; Karaca B
Transplant Proc; 2008; 40(1):151-5. PubMed ID: 18261573
[TBL] [Abstract][Full Text] [Related]
10. Assessment of four biochemical markers of bone metabolism in postmenopausal osteoporosis.
Majkić-Singh N; Ilić M; Ignjatović S; Aleksandra-Postić-Grujin
Clin Lab; 2002; 48(7-8):407-13. PubMed ID: 12146575
[TBL] [Abstract][Full Text] [Related]
11. Serum propeptides of type I and III procollagens in renal transplant recipients. A comparison of cyclosporine and azathioprine treatment.
Heickendorff L; Frost L; Madsen JK; Pedersen EB
Nephron; 1994; 67(2):203-8. PubMed ID: 8072610
[TBL] [Abstract][Full Text] [Related]
12. Long-term biochemical response after bisphosphonate therapy in Paget's disease of bone. Proposed intervals for monitoring treatment.
Alvarez L; Peris P; Guañabens N; Vidal S; Quintó L; Monegal A; Pons F; Ballesta AM; Muñoz-Gómez J
Rheumatology (Oxford); 2004 Jul; 43(7):869-74. PubMed ID: 15054158
[TBL] [Abstract][Full Text] [Related]
13. The concentration of C-terminal propeptide of type I procollagen in blood serum in the course of mandibular fracture healing (preliminary report).
Borys J; Grabowska SZ; Antonowicz B; Dryl D; Citko A; Rogowski F
Rocz Akad Med Bialymst; 2001; 46():251-62. PubMed ID: 11780569
[TBL] [Abstract][Full Text] [Related]
14. Association of adiponectin with procollagen type I carboxyterminal propeptide in non-diabetic essential hypertension.
Tsai WC; Lin CC; Chen JY; Huang YY; Lee CH; Li WT; Weng CM; Chen JH
Blood Press; 2008; 17(4):233-8. PubMed ID: 18671144
[TBL] [Abstract][Full Text] [Related]
15. [Serum levels of carboxyterminal propeptide of type I procollagen (PICP), cross-linked carboxyterminal telopeptide region of type I collagen (ICTP) and carboxyterminal parathyroid hormone-related protein (C-PTHrP) in hematological malignancies with bone lesions and hypercalcemia].
Tanaka K; Shiraishi K; Sakamoto A; Jojima H; Masuchi K; Okubo Y; Tanaka M; Fuzimatsu Y; Fukahori S; Osabe S; Imamura Y; Honda J; Oizumi K
Rinsho Ketsueki; 1998 Apr; 39(4):273-80. PubMed ID: 9597894
[TBL] [Abstract][Full Text] [Related]
16. Changes in blood pressure and renal function following subtotal parathyroidectomy in renal transplant patients presenting with persistent hypercalcemic hyperparathyroidism.
Rostaing L; Moreau-Gaudry X; Baron E; Cisterne JM; Monroziès-Bernadet P; Durand D
Clin Nephrol; 1997 Apr; 47(4):248-55. PubMed ID: 9128792
[TBL] [Abstract][Full Text] [Related]
17. Physical activity combined with massage improves bone mineralization in premature infants: a randomized trial.
Aly H; Moustafa MF; Hassanein SM; Massaro AN; Amer HA; Patel K
J Perinatol; 2004 May; 24(5):305-9. PubMed ID: 15071483
[TBL] [Abstract][Full Text] [Related]
18. Biochemical parameters of bone turnover in kidney transplant recipients.
Smalcelj R; Kusec V; Puretić Z; Mareković Z
Wien Klin Wochenschr; 1998 May; 110(9):326-30. PubMed ID: 9629624
[TBL] [Abstract][Full Text] [Related]
19. Comparison between serum levels of bone alkaline phosphatase and the carboxy-terminal propeptide of type I procollagen as markers of bone formation in patients following renal transplantation.
Withold W; Degenhardt S; Grabensee B; Reinauer H
Clin Chim Acta; 1995 Aug; 239(2):143-51. PubMed ID: 8542652
[TBL] [Abstract][Full Text] [Related]
20. Systemic glucocorticoid treatment decreases serum concentrations of carboxyterminal propeptide of type I procollagen and aminoterminal propeptide of type III procollagen.
Oikarinen A; Autio P; Vuori J; Väänänen K; Risteli L; Kiistala U; Risteli J
Br J Dermatol; 1992 Feb; 126(2):172-8. PubMed ID: 1536783
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]